- 全部删除
- 您的购物车当前为空

Anti-GRO gama/CXCL3 Antibody (5Z21) 是一种 Mouse 抗体,靶向 GRO gama/CXCL3。Anti-GRO gama/CXCL3 Antibody (5Z21) 可用于 ELISA。
Anti-GRO gama/CXCL3 Antibody (5Z21) 是一种 Mouse 抗体,靶向 GRO gama/CXCL3。Anti-GRO gama/CXCL3 Antibody (5Z21) 可用于 ELISA。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
100 μL | ¥ 1,684 | 5日内发货 |
产品描述 | Anti-GRO gama/CXCL3 Antibody (5Z21) is a Mouse antibody targeting GRO gama/CXCL3. Anti-GRO gama/CXCL3 Antibody (5Z21) can be used in ELISA. |
别名 | GRO γ, Gm1960, Dcip1, chemokine (C-X-C motif) ligand 3 |
Ig Type | Mouse IgG1 |
克隆号 | 5Z21 |
交叉反应 | Human |
应用 | ELISA |
推荐剂量 | ELISA: 1:1000-1:2000 |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CXCL3 / GRO gamma (rh CXCL3 / GRO gamma; TMPY-00899; NP_002081.2; Ala35-Asn107). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | CXCL3 is involved in migration, invasion, proliferation and tubule formation of trophoblasts and may play a key role in the pathogenesis of preeclampsia. CXCL3 autocrine/paracrine pathways are involved in the development of prostate cancer by regulating the expression of the target genes that are related to the progression of malignancies. CXCL3 is a novel adipokine that facilitates adipogenesis in an autocrine and/or a paracrine manner through induction of c/ebpb and c/ebpd. CXCL3 and its receptor CXCR2 are overexpressed in prostate cancer cells, prostate epithelial cells and prostate cancer tissues, which may play multiple roles in prostate cancer progression and metastasis. |
偶联 | Unconjugated |
免疫原 | Recombinant Protein: Human CXCL3 / GRO gamma Protein (TMPY-00899) |
抗原种属 | Human |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容